Redefining the IVF Experience for Patients & Providers Using AI
Millions of women and couples in the U.S. are affected by infertility, but only 3% of them use in vitro fertilization (IVF), the most effective medical treatment. The high cost and the uncertainty of the outcome presents significant financial risks and emotional stress, limiting access to IVF treatment for many individuals. Univfy uses AI/ML to improve patients’ experience by providing personalized counseling and accurate IVF success predictions to help women and their partners understand their potential to succeed with IVF. AI supports transparency in treatment outcomes and a true value-based financial program to maximize patients’ probability of having a baby while minimizing or capping financial risks. As importantly, there is significant potential to use AI to address the emotional needs of fertility patients to provide the support needed to navigate treatment.
Dr. Mylene Yao is cofounder and CEO at Univfy, a company that combines healthcare AI, fintech, and scientific validation to power women's access to fertility treatments that are safe and highly effective. Dr. Yao has over 20 years of experience in clinical and scientific research in reproductive medicine. She has led Univfy from founding through stages of technology invention and commercialization and now focuses on scaling Univfy's business.